Wilson Sonsini Goodrich & Rosati advised Aurora Innovation, Inc. on the offering, and Latham & Watkins advised the underwriters. Aurora Innovation, Inc. (Nasdaq: AUR), a self-driving...
Aurora Innovation’s $483 Million Common Stock Offering
Takeda’s $75 Million Investment in Ascentage Pharma
Wilson Sonsini Goodrich & Rosati acted as the U.S. and Hong Kong counsel to Ascentage Pharma in the transaction. Ascentage Pharma Group International (Ascentage Pharma) (6855.HK)...
Aurora’s $820 Million Common Stock Public Offering and Private Placement of Class A Common Stock
Wilson Sonsini Goodrich & Rosati represented Aurora Innovation, Inc. and Latham & Watkins represented the underwriters in the offering. Aurora Innovation, Inc. (Nasdaq: AUR) announced the...
Applied Intuition, Inc.’s Acquisition of Embark Technology, Inc.
Wilson Sonsini advised Embark Technology on the transaction, while Goodwin Procter advised Applied Intuition. Applied Intuition, Inc., a tooling and software provider for autonomous vehicle development,...
Urgent.ly’s Merger With Otonomo
Wilson Sonsini and Herzog Fox represented Urgent.ly, while Latham & Watkins and Gross Kleinhendler represented Otonomo. Urgent.ly, Inc. (“Urgently”) and Otonomo Technologies Ltd. announced that they have entered...
Arcellx’s $4 Billion Collaboration with Kite
Wilson Sonsini Goodrich & Rosati advised Arcellx on the transaction. Clinical-stage biotechnology company Arcellx and Gilead-owned biopharmaceutical company Kite announced a global strategic collaboration to develop...
KnowBe4’s $4.6 Billion Going-Private Transaction
Wilson Sonsini Goodrich & Rosati advised KnowBe4 and Potter Anderson & Corroon advised the Special Committee. Latham & Watkins represented Elephant Partners. Gibson, Dunn & Crutcher...
Aadi Bioscience’s $72.5 Million Private Placement Equity Financing
Wilson Sonsini represented Aadi Bioscience, Inc. on the deal. Aadi Bioscience, Inc., a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in...
Arcellx’s $112 Million Public Offering
Wilson Sonsini advised Arcellx on the deal. Arcellx, a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other...
Inspirato’s Merger with Thayer Ventures Acquisition Corp.
Wilson Sonsini Goodrich & Rosati advised Inspirato on the deal. Simpson Thacher advised UBS Securities LLC, Evercore Group L.L.C., and Stifel, Nicolaus & Company on the...
Alkuri Global’s $4.2 Billion Merger with Babylon Holdings Limited
Sheppard Mullin and Winston & Strawn served as counsel to Alkuri Global Acquisition Corp. on the deal. Freshfields advised Dr. Ali Parsa, Founder, CEO and major...
KnowBe4’s IPO
Wilson Sonsini Goodrich & Rosati advised KnowBe4, Inc. on the deal. KnowBe4, Inc., provider of the leading security awareness platform, announced the pricing of its initial...